Cohen Klingenstein’s Colgate-Palmolive CL Stock Holding History

Cohen Klingenstein’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1M	Sell	153,799 -12,400	-7%	-$1.08M	0.4%	35
2026 Q1	$14.2M	Sell	166,199 -1,950	-1%	-$174K	0.46%	33
2025 Q4	$13.3M	Hold	168,149	–	–	0.4%	32
2025 Q3	$13.4M	Hold	168,149	–	–	0.42%	32
2025 Q2	$15.3M	Hold	168,149	–	–	0.51%	27
2025 Q1	$15.8M	Sell	168,149 -8,000	-5%	-$716K	0.57%	26
2024 Q4	$16M	Sell	176,149 -4,000	-2%	-$382K	0.55%	27
2024 Q3	$18.7M	Sell	180,149 -219	-0.1%	-$22.3K	0.65%	25
2024 Q2	$17.5M	Hold	180,368	–	–	0.64%	24
2024 Q1	$16.2M	Hold	180,368	–	–	0.6%	29
2023 Q4	$14.4M	Hold	180,368	–	–	0.59%	33
2023 Q3	$12.8M	Sell	180,368 -199	-0.1%	-$14.9K	0.58%	32
2023 Q2	$13.9M	Sell	180,567 -2,368	-1%	-$183K	0.6%	31
2023 Q1	$13.7M	Sell	182,935 -2,665	-1%	-$198K	0.65%	31
2022 Q4	$14.6M	Hold	185,600	–	–	0.74%	28
2022 Q3	$13M	Hold	185,600	–	–	0.69%	26
2022 Q2	$14.9M	Hold	185,600	–	–	0.75%	23
2022 Q1	$14.1M	Hold	185,600	–	–	0.58%	30
2021 Q4	$15.8M	Sell	185,600 -4,000	-2%	-$312K	0.63%	29
2021 Q3	$14.3M	Sell	189,600 -15,600	-8%	-$1.24M	0.63%	31
2021 Q2	$16.7M	Hold	205,200	–	–	0.72%	30
2021 Q1	$16.2M	Hold	205,200	–	–	0.75%	30
2020 Q4	$17.5M	Hold	205,200	–	–	0.88%	27
2020 Q3	$15.8M	Hold	205,200	–	–	0.89%	27
2020 Q2	$15M	Hold	205,200	–	–	0.92%	26
2020 Q1	$13.6M	Hold	205,200	–	–	1.01%	23
2019 Q4	$14.1M	Hold	205,200	–	–	0.82%	31
2019 Q3	$15.1M	Buy	205,200 +12,800	+7%	+$929K	0.95%	26
2019 Q2	$13.8M	Sell	192,400 -12,800	-6%	-$909K	0.98%	23
2019 Q1	$14.1M	Buy	205,200 +170,600	+493%	+$11M	0.98%	23
2018 Q4	$2.06M	Hold	34,600	–	–	0.31%	58
2018 Q3	$2.32M	Hold	34,600	–	–	0.29%	58
2018 Q2	$2.24M	Hold	34,600	–	–	0.31%	57
2018 Q1	$2.48M	Hold	34,600	–	–	0.35%	54
2017 Q4	$2.61M	Hold	34,600	–	–	0.37%	54
2017 Q3	$2.52M	Hold	34,600	–	–	0.38%	55
2017 Q2	$2.56M	Hold	34,600	–	–	0.4%	51
2017 Q1	$2.53M	Hold	34,600	–	–	0.41%	48
2016 Q4	$2.26M	Hold	34,600	–	–	0.39%	53
2016 Q3	$2.56M	Hold	34,600	–	–	0.45%	40
2016 Q2	$2.53M	Hold	34,600	–	–	0.47%	36
2016 Q1	$2.44M	Hold	34,600	–	–	0.46%	38
2015 Q4	$2.31M	Hold	34,600	–	–	0.43%	35
2015 Q3	$2.2M	Hold	34,600	–	–	0.43%	36
2015 Q2	$2.26M	Hold	34,600	–	–	0.41%	38
2015 Q1	$2.4M	Hold	34,600	–	–	0.44%	39
2014 Q4	$2.39M	Hold	34,600	–	–	0.45%	39
2014 Q3	$2.26M	Hold	34,600	–	–	0.4%	39
2014 Q2	$2.36M	Hold	34,600	–	–	0.45%	36
2014 Q1	$2.25M	Hold	34,600	–	–	0.45%	37
2013 Q4	$2.26M	Hold	34,600	–	–	0.45%	37
2013 Q3	$2.05M	Hold	34,600	–	–	0.45%	36
2013 Q2	$1.98M	Buy	+34,600	New	+$2.05M	0.46%	36

Other funds holding CL

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Cohen Klingenstein's CL Position: Q2 2026 in Review

Cohen Klingenstein reduced its Colgate-Palmolive (CL) stake by 7.5% in Q2 2026, selling an estimated $1.08M and leaving 153,799 shares worth $14.1M. The position accounts for 0.4% of the portfolio, ranked #35.

Cohen Klingenstein first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.7M in Q3 2024. 840 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Cohen Klingenstein held 153,799 shares of Colgate-Palmolive worth $14.1M as of Q2 2026.
Cohen Klingenstein sold 12,400 Colgate-Palmolive shares in Q2 2026, an estimated $1.08M.
Colgate-Palmolive made up 0.4% of Cohen Klingenstein's portfolio in Q2 2026, its #35 holding.
Cohen Klingenstein first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
Cohen Klingenstein's Colgate-Palmolive position peaked at $18.7M in Q3 2024.
840 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.